Navigation Links
Huiheng Medical, Inc. Announces Agreement to Acquire the ClearPath (TM) Breast Brachytherapy System
Date:6/2/2010

SHENZHEN, China, June 2 /PRNewswire-Asia-FirstCall/ -- Huiheng Medical, Inc. ("Huiheng" or the "Company"; OTC Bulletin Board: HHGM) announces that the Company has entered into an agreement to acquire all of the existing and outstanding shares of Portola Medical, Inc., a Delaware corporation ("Portola"). Portola owns assets consisting of the rights to develop, manufacture and market the ClearPath (TM) breast brachytherapy system ("ClearPath (TM)").

About ClearPath (TM)

ClearPath (TM) is a unique multi-channel catheter brachytherapy, or internal radiation therapy, device used in breast cancer treatments designed to preserve the breast. Early stage breast cancer can often be effectively treated by a combination of a lumpectomy, a surgical procedure to remove a breast tumor, followed by radiation therapy treatment to kill any stray cancer cells around the tumor site that may not have been removed through surgery. Instead of irradiating the entire breast with an external beam of radiation, ClearPath (TM) brachytherapy can be employed to limit radiation exposure to the narrow margin of tissue surrounding the tumor site cavity where the residual cancer cells are most likely to occur.

The ClearPath (TM) device is placed in the resection cavity after a lumpectomy through a single incision. Once inside the cavity, the device expands so that the catheters, which are filled with a radiation source, conform to the shape of and make contact with the walls of the resection cavity, exposing that limited area to radiation. ClearPath's (TM) unique design allows for conformal therapeutic radiation dose distribution during treatment and accommodates both high-dose rate and low-dose rate treatment methods.

ClearPath (TM) was
'/>"/>

SOURCE Huiheng Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Huiheng Medical, Inc. Announces Conference Call to Discuss First Quarter 2010 Results
2. TriReme Medical, Inc. Receives FDA 510(k) Clearance for a Broad Matrix of GliderXtreme(TM) PTA Balloon Catheter Sizes
3. China Sky Medical, Inc. Has 30 Medicines that will Be Included in Chinas National Insurance Directory
4. China Sky One Medical, Inc. Signs Distribution Agreement with MDK for the Sale of Two Diagnostic Kits in Southeast Asia
5. China Sky One Medical, Inc. Announces Conference Call to Discuss Third Quarter 2009 Results
6. New nanotech sensor developed with medical, chemistry applications
7. Aethlon Medical, Inc. Announces Annual Meeting Results
8. China Sky One Medical, Inc. Responds to Concerns Regarding Filed Financial Reports
9. China Sky One Medical, Inc. Announces Record Second Quarter 2009 Results
10. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2009 Results
11. Angiotechs Licensee, Cook Medical, Announces CE Mark Approval and European Launch of the Zilver(R) PTX(R) Stent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... 15, 2014 Freeslate, Inc ., ... announced that Lupin Limited, one of India’s top five ... Protégé PharmD System for high throughput solid form ... focused on a wide range of quality, affordable generic ...
(Date:1/14/2014)... CA (PRWEB) January 14, 2014 Histogen, ... the products of cells grown under simulated embryonic conditions, ... license agreement with Suneva Medical, Inc. for physician-dispensed aesthetic ... , This agreement is an amendment to ...
(Date:1/14/2014)... DIEGO and BETHESDA, Md. ... are joining together with two institutes from the National ... reliable tools for bringing safer, more effective treatments to ... the National Center for Advancing Translational Sciences (NCATS) and ...
(Date:1/14/2014)... OTTAWA, Ontario , Jan. 14, 2014   Kinaxis ®, ... ( SCM ) and sales and operations planning ( S&OP ... the Biomanufacturing Summit , which will be held at ...  At the conference, join Kinaxis customer Elisabeth Kaszas , ...
Breaking Biology Technology:Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3Event Alert: Kinaxis Customer to Present at the Biomanufacturing Summit "Supply Chain: Improving Network Effectiveness" 2
... their outstanding mechanical and electrical properties, carbon ... nanoelectromechanical devices, including high-performance sensors, logic devices, ... associated with creating well-ordered arrays of individual ... modes have prevented any large-scale commercial use. ...
... Inc. (Nasdaq: SGMO ) announced today the presentation ... a disease gene in an animal using systemic delivery of ... made by Sangamo,s collaborators at the 52nd Annual Meeting of ... in Orlando, Florida.   Abst.# 647 "Manipulating ...
... 2010 Cellectis bioresearch, the specialist in genome customization ... it has signed a non-exclusive agreement with Evrogen (Moscow, ... allows Cellectis bioresearch to incorporate these proteins into its ... genome engineering tools. Luc Selig, Sales ...
Cached Biology Technology:Using new materials to make more reliable nanoelectromechanical systems 2Sangamo BioSciences Announces Data Presentation of First In Vivo Demonstration of ZFN-mediated Gene Correction Via Systemic Delivery at American Society for Hematology Meeting 2Sangamo BioSciences Announces Data Presentation of First In Vivo Demonstration of ZFN-mediated Gene Correction Via Systemic Delivery at American Society for Hematology Meeting 3Sangamo BioSciences Announces Data Presentation of First In Vivo Demonstration of ZFN-mediated Gene Correction Via Systemic Delivery at American Society for Hematology Meeting 4Cellectis bioresearch Signs Non-Exclusive License With Evrogen for Access to Fluorescent Proteins 2Cellectis bioresearch Signs Non-Exclusive License With Evrogen for Access to Fluorescent Proteins 3
(Date:4/18/2014)... NC Ancient DNA adds a twist to the story ... to be published April 21 in the journal Proceedings ... from the bones of chickens that lived 200-2300 years ago ... ago domestic chickens may have looked far different from the ... of the traits we associate with modern domestic chickens -- ...
(Date:4/18/2014)... comet impacts can cause widespread ecological havoc, killing off ... But new research from Brown University shows that impacts ... the time of an impact. , A research team ... of leaves and preserved organic compounds lodged inside glass ... material could provide a snapshot of environmental conditions at ...
(Date:4/17/2014)... most densely forested and most densely populated quadrant of ... needs, values and practices. Disturbances associated with those needs, ... development, have set the stage for management issues of ... , The report Five anthropogenic factors that will ... Northern United States was published recently by ...
Breaking Biology News(10 mins):Ancient DNA offers clues to how barnyard chickens came to be 2Impact glass stores biodata for millions of years 2Impact glass stores biodata for millions of years 3Five anthropogenic factors that will radically alter northern forests in 50 years 2Five anthropogenic factors that will radically alter northern forests in 50 years 3
... Kell, published in the journal Archives of Toxicology ... are in part caused by poorly-bound iron which causes ... the components of living systems. , These toxins, called ... different parts of the body. , In order to ...
... Many U.S. restaurants may be ignoring a desire by American ... small exploratory study. Researchers found that more than 8 ... would be willing to pay more to dine at "green" ... good for restaurants to protect the environment. The only ...
... New Rochelle, NY, December 7, 2010NASA-funded research has uncovered ... can not only survive but can thrive and reproduce ... for most other earthly organisms. This finding will revolutionize ... distribution, and future of life in the universe. ...
Cached Biology News:See off Alzheimer's with the color purple 2Diners may be willing to pay more to eat at 'green' restaurants 2Diners may be willing to pay more to eat at 'green' restaurants 3Field of astrobiology more vital than ever 2
Mouse monoclonal [1.F.1] to Yersinia pestis F1 antigen ( Abpromise for all tested applications). Antigen: Purified F1 antigen of Y. pestis vaccine strain EB....
7G10 anti-Fasciclin III...
Rabbit polyclonal to Nck alpha ( Abpromise for all tested applications). entrezGeneID: 4690 SwissProtID: P16333...
Rabbit polyclonal to P5 ( Abpromise for all tested applications). entrezGeneID: 10954 SwissProtID: Q14554...
Biology Products: